trial

Disturbances of Kynurenine Pathway of Trytophan Metabolism in Schizophrenia: A Quantitative Reverse Transcription Polymerase Chain Reaction (RT-PCR) Study

NCTId NCT00573300
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 60 (estimated)
Sponsored by North Suffolk Mental Health Association
Primary completion 2009-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2006-01
Primary completion
2009-05
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Phlebotomy

Sponsors

North Suffolk Mental Health AssociationLead Sponsor

Investigators

1
Oliver Freudenreich, M.D.Principal Investigator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2009-05
Status
COMPLETED
relationships
The graph out of here
drug
Phlebotomy
drug
lead_sponsor
North Suffolk Mental Health Association
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Oliver Freudenreich, M.D.
person